1. Market Research
  2. > Therapy
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

About 2500 reports for Salicylic Acid (page 126)

Purchase Reports From Reputable Market Research Publishers

3D & 4D Technology Market by Technology , and Region - Global Forecast to 2022

  • $ 4950
  • April 2016
  • 192 pages

The modular vision systems division develops, manufactures, and markets modular vision systems and ID products that are used to automate the manufacturing and tracking of discrete items such as cellular phones, aspirin bottles, and automobile wheels by locating, identifying, inspecting, and

  • Input Output Device
  • Recreational Activity
  • United States
  • Market Size
  • Stratasys Ltd.

Hypertriglyceridemia - Pipeline Review, H1 2016

  • $ 2000
  • June 2016
  • 106 pages

The patent also protects the use of these Cardax compounds in combination with well-known anti-inflammatory treatments such as prednisone and other steroids as well as celecoxib (Celebrex), aspirin, naproxen, ibuprofen, and other NSAIDs.

  • Hospital
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Acasti Pharma Inc.

Taro Pharmaceuticals U.S.A., Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • March 2016
  • 27 pages

Neosalus is a non-steroidal anti-inflammatory prescription topical foam formulation, while Cleanse & Treat is a prescription drug product indicated for the topical treatment of acne, containing both a salicylic acid cleansing pad and a benzoyl peroxide treatment pad.

  • Pharmaceutical
  • Salicylic Acid
  • United States
  • Company
  • Taro Pharmaceuticals U.S.A., Inc.

Axxess Pharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • March 2016
  • 32 pages

Vendor, acquirer, target and partner report for Axxess Pharma, Inc. and its subsidiaries.

  • Pharmaceutical
  • Canada
  • Company
  • M&A
  • Axxess Pharma, Inc.

Eisai Co., Ltd. - Product Pipeline Review - 2016

  • $ 1500
  • August 2016
  • 181 pages

Pariet is used in the prevention of recurrent gastric or duodenal ulcers caused by low-dose aspirin therapy. lorcaserin hydrochloride menatetrenone paclitaxel SR perampanel rabeprazole sodium DR Pariet is under development for maintenance therapy for proton pump inhibitor (PPI)-resistant re

  • Infectious Disease
  • Research And Development
  • Salicylic Acid
  • Therapy
  • Eisai Co., Ltd.

Johnson & Johnson - Product Pipeline Review - 2016

  • $ 1500
  • March 2016
  • 423 pages

The trial will assess Xarelto in combination with dual antiplatelet therapy and when aspirin is not used.

  • Infectious Disease
  • Monoclonal Antibody
  • Salicylic Acid
  • Targeted Therapy
  • Therapy

Merck & Co., Inc. (formerly Schering-Plough Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • June 2016
  • 998 pages

Aspirin and Clopidogrel.

  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Merck & Co., Inc.

Global Diesel Fuel Additives Market by Type, by Geography - Analysis & Forecast to 2019

  • $ 4174
  • May 2015
  • 106 pages

The report covers the global diesel additives market and further divides the market on the basis of type and geography. The market data for these types is given with respect to volume (kilotons) and value ...

  • Chemical
  • Fuel Additive
  • Specialty Chemical
  • World
  • Market Size

The Global Market for Biomarkers (Cancer Biomarkers, Cardiovascular Disease Biomarkers, Immunological Disease Biomarkers, Infectious Disease Biomarkers, Neurological Disease Biomarkers, Novel Biomarkers for Other Diseases)

  • $ 4200
  • December 2015
  • 683 pages

AspirinWorks is an FDA cleared urine test that to measure levels of ##-dehydro thromboxane B## (##dhTxB##) to determine aspirin effect in apparently healthy individuals.

  • Biomarker
  • Diagnostics
  • Genomics
  • Salicylic Acid
  • Roche Group

Bayer AG - Product Pipeline Review - 2016

  • $ 1500
  • April 2016
  • 250 pages

The Phase III study COMPASS will assess the potential of rivaroxaban to provide important additional protection to patients when added to aspirin as compared to rivaroxaban and aspirin as single treatments.

  • Monoclonal Antibody
  • Oncology
  • Salicylic Acid
  • Targeted Therapy
  • Therapy

Venous thromboembolism

  • $ 5000
  • April 2016
  • 230 pages

Both of those doses should be more effective than aspirin.

  • Blood Disease
  • Cardiovascular Disease
  • Healthcare
  • Salicylic Acid
  • Therapy

Platelet Aggregation Devices Market by Product, Application, End User - Global Forecasts to 2020

  • $ 4950
  • August 2015
  • 137 pages

Therefore, such diagnosis may display a false " aspirin-like defect" in patients, who are not on such medications.

  • Blood Supply
  • Healthcare
  • Salicylic Acid
  • North America
  • United States

Cilag GmbH International – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • March 2016
  • 52 pages

salicylic acid solution, an anti-corn preparation), Tirgon(R) (bisacodyl for constipation) and Xitix(R) (vitamin C lozenges to treat vitamin C deficiency).

  • Pharmaceutical
  • Salicylic Acid
  • Company
  • M&A
  • Cilag GmbH

sanofi-aventis U.S. LLC. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • June 2016
  • 62 pages

Under the terms of the agreement, Sanofi will have exclusive rights to commercialize all PA combinations that contain ## mg or less of enteric-coated aspirin in the US.

  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • United States
  • Sanofi S.A.

Bristol-Myers Squibb Company - Product Pipeline Review - 2016

  • $ 1500
  • March 2016
  • 255 pages

This interim analysis also demonstrated an acceptable safety profile for apixaban compared to aspirin.

  • Research And Development
  • Salicylic Acid
  • Therapy
  • United States
  • Bristol-Myers Squibb Company

Astellas Pharma Inc. - Product Pipeline Review - 2016

  • $ 1500
  • May 2016
  • 285 pages

The results demonstrated that ASP## functions as a highly selective COX-## inhibitor with a superior ability to aspirin for normalizing TXA##/ PGI## balance, and exerts antithrombotic effect without ulcerogenic effect.

  • Pharmaceutical
  • Research And Development
  • Salicylic Acid
  • Therapy
  • Astellas Pharma Inc.

Plethora Solutions Holdings plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • June 2016
  • 61 pages

a Switzerland-based biopharmaceutical company, for Prosed(R) DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate) in the US.

  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Corporate Finance
  • Recordati S.p.A.

Novartis AG - Product Pipeline Review - 2016

  • $ 1500
  • March 2016
  • 489 pages

R& D Progress Research and Development Brief Company reported the discovery, by an integrated lead finding approach, of two new chemical classes of allosteric FPPS inhibitors that belong to the salicylic acid and quinoline chemotypes.

  • Leukemia
  • Salicylic Acid
  • Targeted Therapy
  • Therapy
  • Novartis AG

Kaiser Permanente – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • June 2016
  • 246 pages

Private Private Accumetrics, Inc. is a developer, manufacturer, and marketer of the VerifyNow(R) System, a point-of-care (POC )system used to measure platelet reactivity following antiplatelet therapies, including adenosine diphosphate (ADP) receptor antagonists and aspirin.

  • Healthcare
  • Salicylic Acid
  • United States
  • Company
  • Permanente Medical Group

Global Gasoline Fuel Additives Market by Type, by Geography - Analysis and Forecast to 2019

  • $ 4174
  • May 2015
  • 107 pages

Infineum began construction for its new salicylate plant, the first for the company outside Europe, situated on Jurong Island in Singapore, to provide products for the customers in Asia-Pacific region.

  • Chemical
  • Fuel Additive
  • Specialty Chemical
  • World
  • Market Size
View report >

Hospital Social Impact in Texas (USA)

  • January 2019
  • 70 pages

OF ##, ## MI CASES SEEN BETWEEN 2008 AND 2018, ##. ##% WERE PRESCRIBED ASPIRIN WITHIN THE FIRST ## HOURS OF EITHER FIRST MEDICAL CONTACT OR HOSPITAL ARRIVAL, ##. ##% WERE NOT PRESCRIBED ASPIRIN, AND ##. ##% HAD CONTRAINDICATIONS TO ASPIRIN USE (PG. ##).

  • Health Services
  • Heart Attack
  • Hospital
  • Salicylic Acid
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on